Conjugate vaccines - Open Access .click

Results 311 to 320 of about 77,026 (328)

Some of the next articles are maybe not open access.

Conjugate pneumococcal vaccines: an overview

Medical Journal of Australia, 2000
A seven-valent conjugate pneumococcal vaccine has been shown to have dramatic efficacy against invasive pneumococcal disease and lesser efficacy against otitis media and pneumonia. This vaccine was licensed for use in infants in the United States in February 2000 and is recommended there for routine use in infants and catch-up vaccination in high-risk ...
openaire +3 more sources

Immunogenicity of pneumococcal conjugate vaccines

The Pediatric Infectious Disease Journal, 2000
Prevention of pneumococcal infections is a public health priority because of the high impact of the disease and because of the increasing problems due to antimicrobial resistance. Traditional vaccines, consisting of purified capsular polysaccharides (PSs) of Streptococcus pneumoniae, are not immunogenic in young children.
openaire +3 more sources

Meningococcal tetravalent conjugate vaccine

Expert Opinion on Biological Therapy, 2008
Neisseria meningitidis is a leading cause of meningitis and sepsis worldwide. Since 1981, a tetravalent meningococcal polysaccharide vaccine has been available in the US but it has been limited to high-risk patients and outbreak settings. In 2005, a tetravalent polysaccharide meningococcal conjugate vaccine (MCV4) was licensed for routine use in the US.
openaire +3 more sources

Pneumococcal conjugate vaccines